David Zezza

We use artificial intelligence and machine learning to transform basic physiologic data into life saving and life changing vital signs

Ice Energy was a pioneering thermal energy storage company. Its assets, including the industry leading Ice Bear thermal energy storage technology were acquired in 2020 by Thule Energy Storage, https://www.linkedin.com/company/thule-energy-storage

PharmaMax is a innovation powerhouse within the Chinese pharmaceutical and consumer healthcare industry. PharmaMax is dedicated to improving the health and quality of life of China’s residents through highly innovative, world class quality products to treat chronic conditions. Its international management team have developed and commercialized over 250 new products for the global marketplace. PharmaMax, founded in 2009 is based in Taizhou City, Jiangsu Province and New Jersey, USA. The privately held company is a China-American joint venture between Jiangsu Changtai LTD and PharmaMax USA. This structure provides the perfect blend of international quality, scientific standards and governance with the ability to execute flawlessly within the complex regulatory environment of China. The PharmaMax portfolio is focused on high value prescription and consumer healthcare products which treat chronic conditions. In addition, PharmaMax strategically partners with a number of international companies from the US and EU to bring breakthorough products to the massive China marketplace. For other customers, it offers turn-key "concept to commercialization" capabilities and services. The PharmaMax facilities are strategically located in Taizhou City and within the Chinese Medical City (CMC). Our current facility is 3,000 square meters of floor space for R&D, cGMP Manufacturing and Office Adminstration. PharmaMax is expanding operations to a new 16,000 square meter cGMP facility and company headquarters in early 2015. PharmaMax and its strategic partners benefit from a number of special privileges intended to facilitate and expedite registrations and approvals as well as support to protect against IP infringement in China.

Founded by senior executives with decades of investment experience, Thesiger (ˈθɛsɪdʒə) focuses on Europe’s strategic autonomy and resilience in the face of evolving security challenges. The firm deploys capital in critical sectors essential for European capabilities in order to strengthen the security infrastructure in Europe. We call our USP, "The Thesiger Advantage," consisting of our expertise and network. 1. Strategic Capital - We provide growth financing to sectors essential to building strategic autonomy. 2. Security Focus - We focus on the full spectrum of security infrastructure across Europe. 3. Long Term Vision - We work in partnership to help high growth businesses reach their full potential, driving economic growth and resilience. We are on a mission to finance Europes strategic autonomy. 1. Industry Specialists - Our team brings decades of experience in financing critical sectors in Europe. 2. Government Connections - We leverage an extensive network of relationships with key European policy makers and security agencies. 3. Technical Knowledge - Our advisors bring a wealth of strategic and technical expertise, helping leading edge companies achieve their objectives.

The Ascension Life Fund focuses on UK HealthTech and Life Sciences companies raising Seed+ funding rounds that bridge the equity gap between Seed and Series A rounds. The funds investments focus on the convergence between technology and life sciences, especially between diagnostics, personalised medicine and data science. The funds investment themes are: Healthcare Data & Platforms, Digital Therapeutics & Biomarkers, Diagnostics & Genomics, MedTech, incl. Medical Devices, Applied AI in Life Sciences & Healthcare, and Pharmaceutical Value Chain. The Ascension Life Fund has an exceptional network of advisors who assist with due diligence and the fund always looks to add value to our portfolio companies.

Portugals top rated fund manager offers the Portugal Gateway Golden Visa fund

Kigeni Ventures is an international venture capital fund with operations across Africa and in Asia and Europe.

Portugal Ventures, a venture capital firm that is part of the Banco Português de Fomento group, currently manages 282 million euros and has 164 portfolio companies. It invests in startups in the pre-seed, seed and series A stages that offer innovative solutions for the international market in the digital & technology, industry & technology, therapeutics & health tech, and tourism sectors. Since 2012, Portugal Ventures has invested 208.1 million euros in 237 new businesses.